AWHL

Aspira Women's Health Inc.

OTC · In Vitro & In Vivo Diagnostic Substances · Inc. DE · CIK 0000926617
$0.5000 +2.04%
Insider Buying Cluster (2 insiders)
Vol
Inst. Holders11 funds
Inst. Value$30.1K
Inst. Activity2 buys / 0 sells
Insider Activity6B / 0S
Insider Net $$132.4K
SEC Reports5
Exchange OTC·Sector In Vitro & In Vivo Diagnostic Substances·Inc. DE·CIK 0000926617·Prev Close $0.4900

Top Institutional Holders

FundValueMove
DANSKE BANK A/S
ROYAL BANK OF CANADA
BlackRock, Inc.$7.7K
VANGUARD GROUP INC$7.4K
BANK OF AMERICA CORP$5.9KADD

Recent Insider Trades

DateInsiderTypeValue
Jun 5, 2026SCHULER JACKBUY$0.00
Jun 5, 2026SCHULER JACKBUY$100.0K
Sep 17, 2025cohen JeffreyJ$5.0K
Sep 17, 2025cohen JeffreyBUY$25.0K
Sep 17, 2025cohen JeffreyBUY$0.00
11 institutional holders with $30.1K total value (502,968 shares) as of 2025-Q1. Top holders: DANSKE, ROYAL, BlackRock,. Net buying activity: 2 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q1

#FundSharesValue% of TrackedLast Move
1DANSKE BANK A/S1$0.000.0%
2ROYAL BANK OF CANADA100$0.000.0%
3BlackRock, Inc.82,232$7.7K25.7%
4VANGUARD GROUP INC79,183$7.4K24.7%
5BANK OF AMERICA CORP /DE/63,528$5.9K19.6%ADD +80.6%
6UBS Group AG34,196$3.2K10.7%DOUBLED +1572.2%
7PNC FINANCIAL SERVICES GROUP, INC.25,000$2.4K7.8%ADD +66.7%
8STATE STREET CORP19,749$1.9K6.2%
9M&T BANK CORP14,999$1.4K4.7%
10MORGAN STANLEY1,694$159.000.5%TRIM -33.3%
11HRT FINANCIAL LP182,286$17.000.1%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
UBS Group AGDOUBLED2,04534,196+1572.2%$3.2K2025-Q1
PNC FINANCIAL SERVICES GROUP, INC.ADD15,00025,000+66.7%$2.4K2025-Q1
BANK OF AMERICA CORP /DE/ADD29,34652,994+80.6%$42.9K2024-Q3
MORGAN STANLEYTRIM2,4221,616-33.3%$1.3K2024-Q3
3 unique insiders with 7 transactions. Net insider value: $132.4K ($132.4K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 5, 2026SCHULER JACK W10%+ OwnerBUY300,000
Jun 5, 2026SCHULER JACK W10%+ OwnerBUY222,222$0.4500$100.0K
Sep 17, 2025cohen Jeffrey kDirectorJ11,112$0.4500$5.0K
Sep 17, 2025cohen Jeffrey kDirectorBUY55,556$0.4500$25.0K
Sep 17, 2025cohen Jeffrey kDirectorBUY41,667
Sep 17, 2025Fraser John DDirectorBUY16,389$0.4500$7.4K
Sep 17, 2025Fraser John DDirectorBUY12,292

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution: 80% buy across 5 analysts — 1 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
2025-06-30
$0.00 $0.00 $0.00 $0.0B
Current FY
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20251310080%
May 1, 20251310080%
Apr 1, 20251310080%
Mar 1, 20251310080%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.